It has been previously addressed that depleted ASXL1 might be related to lymphatic invasion of CRC, which suggests that ASXL1 is likely to function as a tumor suppressor in CRC (Lee et al., 2020). This evidence concerns the gene ASXL1 and colorectal carcinoma.